BEIJING, PR China. – August, 2007 –

The ChinaCare Group, the only international healthcare consulting firm in mainland China, announced today that it has been retained by the People’s Liberation Army Hospital in Fuzhou, People’s Republic of China, to assist in the development of a highly advanced particle therapy center in Fuzhou. In this capacity, the firm will provide business development and advisory services intended to assist the project in the attraction of investors.
Particle therapy is a highly advanced modality for the treatment of cancer which attacks cancerous cells through ionization. Using either proton or ion therapy, particle therapy centers are able to provide far more effective treatment with less damage to neighboring tissue. Five-year survival rates of patients who have utilized this modality exceed 80%. The proposed Fuzhou center will be one of only a handful of centers in existence in the world today.

____________________________

About The ChinaCare Group
The ChinaCare Group is dedicated to the development of the healthcare industry in all of its sectors, public and private, for-profit and not-for-profit, in the People’s Republic of China. Realizing the opportunities of this marketplace and operating effectively in it, requires knowledge, insight and practical experience. This is the role of the ChinaCare Group. We provide our clients with practical solutions on strategy, technology, operations and organization.

Media Contacts:
Jia Xiaofeng
The ChinaCare Group
+86 10-5869-0905
cipherjia@chinacaregroup.com

The ChinaCare Group and The ChinaCare Group logo are registered trademarks. All other company and product names may be trademarks of their respective owners. Copyright 2004 The ChinaCare Group, CO., LTD. All rights reserved.